Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine

Metaphase cytogenetics (MC) has a major role in the risk stratification of patients with myelodysplastic syndromes (MDSs) and can affect the choice of therapies. Azacitidine (AZA) has changed the outcome of patients with MDS or acute myeloid leukemia (AML) unfit for intensive chemotherapy. Identific...

詳細記述

保存先:
書誌詳細
主要な著者: Cluzeau, T, Moreilhon, C, Mounier, N, Karsenti, J-M, Gastaud, L, Garnier, G, Re, D, Montagne, N, Gutnecht, J, Auberger, P, Fuzibet, J G, Cassuto, J-P, Raynaud, S
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2013
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3880435/
https://ncbi.nlm.nih.gov/pubmed/24185502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2013.52
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料